Literature DB >> 7622894

Limited persistence in and subsequent elimination of Pneumocystis carinii from the lungs after P. carinii pneumonia.

S L Vargas1, W T Hughes, A E Wakefield, H S Oz.   

Abstract

The purpose of this study was to determine the period of persistence of Pneumocystis carinii in the lungs after P. carinii pneumonitis (PCP). After primary PCP was induced with dexamethasone, experimental rats were moved to a high-efficiency particulate air-filtered isolator to prevent further exposure to environmental P. carinii and allowed to recover. At intervals thereafter, sample groups were transferred to a second isolator and reimmunosuppressed with dexamethasone to provoke PCP if P. carinii were present. Reactivation of PCP was assessed by histologic examination, counts of cysts per gram of lung, and DNA amplification using nested polymerase chain reaction. A sequential and progressive decrease in P. carinii was detected. Thus, P. carinii is cleared from the lungs of > or = 75% of animals within 1 year after an episode of PCP, implying that persistence of latent organisms is limited.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7622894     DOI: 10.1093/infdis/172.2.506

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  28 in total

Review 1.  Genetics of surface antigen expression in Pneumocystis carinii.

Authors:  J R Stringer; S P Keely
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

2.  Magnetic bead capture eliminates PCR inhibitors in samples collected from the airborne environment, permitting detection of Pneumocystis carinii DNA.

Authors:  N Maher; H K Dillon; S H Vermund; T R Unnasch
Journal:  Appl Environ Microbiol       Date:  2001-01       Impact factor: 4.792

3.  Heterogeneity and compartmentalization of Pneumocystis carinii f. sp. hominis genotypes in autopsy lungs.

Authors:  J Helweg-Larsen; B Lundgren; J D Lundgren
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

Review 4.  Extrapulmonary pneumocystosis.

Authors:  V L Ng; D M Yajko; W K Hadley
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

Review 5.  Treatment of infection due to Pneumocystis carinii.

Authors:  J A Fishman
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

6.  Study of internal transcribed spacer and mitochondrial large-subunit genes of Pneumocystis carinii hominis isolated by repeated bronchoalveolar lavage from human immunodeficiency virus-infected patients during one or several episodes of pneumonia.

Authors:  S Latouche; J L Poirot; C Bernard; P Roux
Journal:  J Clin Microbiol       Date:  1997-07       Impact factor: 5.948

Review 7.  Pneumocystis carinii: what is it, exactly?

Authors:  J R Stringer
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

Review 8.  Pentamidine in Pneumocystis jirovecii prophylaxis in heart transplant recipients.

Authors:  Adem Ilkay Diken; Ozlem Erçen Diken; Onur Hanedan; Seyhan Yılmaz; Ata Niyazi Ecevit; Emir Erol; Adnan Yalçınkaya
Journal:  World J Transplant       Date:  2016-03-24

9.  Identification of Pneumocystis carinii f. sp. hominis gene sequences in filtered air in hospital environments.

Authors:  M Olsson; C Lidman; S Latouche; A Björkman; P Roux; E Linder; M Wahlgren
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

10.  Genetic variation in Pneumocystis carinii isolates from different geographic regions: implications for transmission.

Authors:  C B Beard; J L Carter; S P Keely; L Huang; N J Pieniazek; I N Moura; J M Roberts; A W Hightower; M S Bens; A R Freeman; S Lee; J R Stringer; J S Duchin; C del Rio; D Rimland; R P Baughman; D A Levy; V J Dietz; P Simon; T R Navin
Journal:  Emerg Infect Dis       Date:  2000 May-Jun       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.